Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
Andreas Linkermann, Chair – Department of Internal Medicine V – Nephrology at Ruprecht-Karls-Universität Heidelberg, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nature Cell Biology, adding:
”Publication alert – Nature Cell Biology –
Mechanisms underlying propagation of ferroptotic cell death
Cell death propagation by ferroptosis represents a dynamic feature of tissue damage which occurs in diseases such as strokes, heart attacks and episodes of acute kidney injury and kidney tubular necrosis.
Scientifically, it is a fascinating topic which we have been excited to study over the last decade.
In a first, together with the team of Derek Pratt, we (Francesca Maremonti and Nadja Leinung) review our current understanding of that process starting with the chemical reactions that underly intermolecular spreading of lipid peroxidation within biological membranes.
Such reactions, we propose, transfer the deadly from cell to cell to expand tissue damage in diseases.
We argue that it is of clinical importance to detect factors that shape the anti-ferroptotic frontline within tissues the resilience of which defines the speed of cell death propagation. Teams of Tom Vanden Berghe and Koen Augustyns have recently treated human transplants with ferroptosis inhibitors. It is out hope to transfer this knowledge to clinical applications in the near future.
We are greateful to the editors of nature cell biology, in particular Petra Gross, Zhe Wang and Christina Kary for providing this outstanding platform.”
Title: Mechanisms underlying propagation of ferroptotic cell death
Authors: Francesca Maremonti, Alireza Dehdari, Nadja Leinung, Derek A. Pratt, Andreas Linkermann
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 12, 2026, 17:39Annie Bauzon: Differentiating Direct and Indirect Coombs Tests in Hematology
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026